References
- Goldman JM, Apperly JF, Jones L, Marous R, Goolden AM, Batchelor R, Hale G, Waldman H, Reid CD, Hows J, Gordon-Smith E, Catovsky D, Galton D AG. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 1986; 314: 202–207
- Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954–1956
- Enright H, Davies SM, De For T, Shu X, Weisdorf E, Miller W, Ramsay N KC, Arthur D, Verfaillie C, Miller J, Kersey J, McGlave P. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation, for chronic myeloid leukemia; early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective. Blood 1996; 88: 714–720
- Kantarajan HM, O'Brien S, Anderlini P, Talpaz M. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996; 87: 3069–3081
- Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwann FE, Bortin MM. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562
- Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffman RG, Jacobsen SJ, Marmont AM, McGlave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS, Bortin MM. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806–815
- Kolb HG, Mittermueller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462–2465
- Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041–2050
- Frassoni F, Sessarego M, Bacigalupo A, Strada P, Repetto M, Miceli S, Occhini D, Defferrari R, Marmont A. Competition between recipient and donor cells after bone marrow transplantation for chronic myeloid leukaemia. Brit Jnl Haem 1988; 69: 471–475
- Alkam M, Bradstock KF, Hughes WG, Watson N, Bowyer I. Spontaneous complete remission of chronic myeloid leukaemia following haematological relapse after allogeneic bone marrow transplantation. Aust NZ J Med 1990; 20: 710–712
- Bocchia M, Korontsuit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA. Specific human cellular immunity to bcr-abl ongene-derived peptides. Blood 1996; 87: 3587–3592
- Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for, a persistent problem. Blood 1994; 84: 2061–2067
- Jones RJ, Vogelsang GB, Hess AD, Farmer ER, Mann RB, Geller RB, Piantadosi S, Santos GW. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; I: 754–756